Published in J Cell Mol Med on December 20, 2005
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers | NCT04791449
Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice. Circulation (2010) 1.97
Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med (2006) 1.93
In vivo models of angiogenesis. J Cell Mol Med (2006) 1.74
HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J Cell Biol (2006) 1.62
Notch signaling in the vasculature. Curr Top Dev Biol (2010) 1.62
IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A (2010) 1.56
A pilot study of long-acting octreotide for symptomatic malignant ascites. Oncology (2012) 1.56
Vascular endothelial growth factor: biology and therapeutic applications. Int J Biochem Cell Biol (2007) 1.55
Roles for VEGF in the adult. Microvasc Res (2007) 1.48
Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med (2007) 1.48
Diabetes-induced superoxide anion and breakdown of the blood-retinal barrier: role of the VEGF/uPAR pathway. PLoS One (2013) 1.43
Prokaryotic Soluble Overexpression and Purification of Human VEGF165 by Fusion to a Maltose Binding Protein Tag. PLoS One (2016) 1.39
Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr Cancer (2009) 1.31
Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical science. J Cell Mol Med (2007) 1.31
Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther (2010) 1.30
Mitogen-activated protein kinases and their role in radiation response. Genes Cancer (2013) 1.26
Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther (2007) 1.23
VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism. J Biol Chem (2008) 1.19
Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue. Ann N Y Acad Sci (2012) 1.17
Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol (2010) 1.12
Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells. Mol Cancer Res (2008) 1.12
Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy. Neoplasia (2008) 1.08
Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J Cell Mol Med (2010) 1.07
The role of PGE2 receptor EP4 in pathologic ocular angiogenesis. Invest Ophthalmol Vis Sci (2009) 1.07
Functional VEGF and VEGF receptors are expressed in human medulloblastomas. Neuro Oncol (2007) 1.04
Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat model. J Cell Mol Med (2006) 1.04
Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions. Hum Immunol (2009) 1.03
Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6). J Cell Mol Med (2007) 1.03
PDGF/VEGF signaling controls cell size in Drosophila. Genome Biol (2009) 1.01
Calorie restriction and cancer prevention: a mechanistic perspective. Cancer Metab (2013) 1.01
Expression of endoglin (CD105) in cervical cancer. Br J Cancer (2009) 1.01
Priming adult stem cells by hypoxic pretreatments for applications in regenerative medicine. J Biomed Sci (2013) 1.00
Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane. Arthritis Res Ther (2008) 1.00
MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib. Neuro Oncol (2010) 0.99
Upregulation of vascular endothelial growth factor isoform VEGF-164 and receptors (VEGFR-2, Npn-1, and Npn-2) in rats with cyclophosphamide-induced cystitis. Am J Physiol Renal Physiol (2008) 0.99
Bioceramic-mediated trophic factor secretion by mesenchymal stem cells enhances in vitro endothelial cell persistence and in vivo angiogenesis. Tissue Eng Part A (2012) 0.98
Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med (2010) 0.98
Protein therapeutics for cardiac regeneration after myocardial infarction. J Cardiovasc Transl Res (2010) 0.97
Dynamics of preventive vs post-diagnostic cancer control using low-impact measures. Elife (2015) 0.97
Evaluation of blood vessel ingrowth in fibrin gel subject to type and concentration of growth factors. J Cell Mol Med (2008) 0.96
Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo. BMC Cancer (2009) 0.95
Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice. BMC Cancer (2010) 0.94
Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2. J Immunother (2010) 0.94
Saikosaponin-d Enhances the Anticancer Potency of TNF-α via Overcoming Its Undesirable Response of Activating NF-Kappa B Signalling in Cancer Cells. Evid Based Complement Alternat Med (2013) 0.94
Soluble and insoluble signals and the induction of bone formation: molecular therapeutics recapitulating development. J Anat (2006) 0.93
A novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNA. PLoS Med (2008) 0.93
Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy. Nutrients (2016) 0.93
Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer. Pathol Oncol Res (2011) 0.91
Hypoxia differentially regulates arterial and venous smooth muscle cell proliferation via PDGFR-β and VEGFR-2 expression. Am J Physiol Heart Circ Physiol (2011) 0.91
Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610. Radiat Oncol (2013) 0.90
Understanding the natural biology of kidney cancer: implications for targeted cancer therapy. Rev Urol (2007) 0.90
The role of the RhoA/Rho kinase pathway in angiogenesis and its potential value in prostate cancer (Review). Oncol Lett (2014) 0.89
Novel vascular endothelial growth factor D variants with increased biological activity. J Biol Chem (2009) 0.89
Intrabronchial infection of rhesus macaques with simian varicella virus results in a robust immune response in the lungs. J Virol (2014) 0.88
Multifaceted leptin network: the molecular connection between obesity and breast cancer. J Mammary Gland Biol Neoplasia (2013) 0.88
Hypoxia enhances FGF2- and VEGF-stimulated human placental artery endothelial cell proliferation: roles of MEK1/2/ERK1/2 and PI3K/AKT1 pathways. Placenta (2009) 0.88
Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress. Curr Cardiol Rev (2008) 0.88
hSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers. PLoS One (2011) 0.87
Protein phosphatase 3 differentially modulates vascular endothelial growth factor- and fibroblast growth factor 2-stimulated cell proliferation and signaling in ovine fetoplacental artery endothelial cells. Biol Reprod (2008) 0.87
Regulation of renal cell carcinoma cell proliferation, invasion and metastasis by connexin 32 gene. J Membr Biol (2007) 0.87
Beneficial effect of mechanical stimulation on the regenerative potential of muscle-derived stem cells is lost by inhibiting vascular endothelial growth factor. Arterioscler Thromb Vasc Biol (2013) 0.86
Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas. Mol Cancer (2006) 0.86
Radiotherapy in combination with vascular-targeted therapies. Radiol Oncol (2010) 0.86
Gram-positive pathogenic bacteria induce a common early response in human monocytes. BMC Microbiol (2010) 0.85
De novo morphogenesis of testis tissue: an improved bioassay to investigate the role of VEGF165 during testis formation. Reproduction (2014) 0.84
Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitors. PLoS One (2010) 0.84
Tumour progression and liver regeneration--insights from animal models. Nat Rev Gastroenterol Hepatol (2013) 0.84
A pharmacokinetic binding model for bevacizumab and VEGF165 in colorectal cancer patients. Cancer Chemother Pharmacol (2015) 0.84
VEGFA family isoforms regulate spermatogonial stem cell homeostasis in vivo. Endocrinology (2011) 0.84
Deconvoluting the obesity and breast cancer link: secretome, soil and seed interactions. J Mammary Gland Biol Neoplasia (2013) 0.83
Direct contact of umbilical cord blood endothelial progenitors with living cardiac tissue is a requirement for vascular tube-like structures formation. J Cell Mol Med (2011) 0.83
Dietary energy balance modulates ovarian cancer progression and metastasis. Oncotarget (2014) 0.83
Major liver resection stimulates stromal recruitment and metastasis compared with repeated minor resection. J Surg Res (2012) 0.82
Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury. PLoS One (2014) 0.82
Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics. Br J Pharmacol (2015) 0.82
Expression and purification of functional human vascular endothelial growth factor-a121; the most important angiogenesis factor. Adv Pharm Bull (2014) 0.82
Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. Cancer Epidemiol Biomarkers Prev (2010) 0.82
Genomic analysis of human lung fibroblasts exposed to vanadium pentoxide to identify candidate genes for occupational bronchitis. Respir Res (2007) 0.82
Soluble factors from the notochordal-rich intervertebral disc inhibit endothelial cell invasion and vessel formation in the presence and absence of pro-inflammatory cytokines. Osteoarthritis Cartilage (2014) 0.82
Pien Tze Huang Inhibits Hypoxia-Induced Angiogenesis via HIF-1 α /VEGF-A Pathway in Colorectal Cancer. Evid Based Complement Alternat Med (2015) 0.82
Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells. J Cell Mol Med (2008) 0.81
In silico discovery of potential VEGFR-2 inhibitors from natural derivatives for anti-angiogenesis therapy. Int J Mol Sci (2014) 0.81
Tumor growth decreases NK and B cells as well as common lymphoid progenitor. PLoS One (2008) 0.81
Indirubin derivative E804 inhibits angiogenesis. BMC Cancer (2012) 0.81
Placenta growth factor and vascular endothelial growth factor B expression in the hypoxic lung. Respir Res (2011) 0.81
Immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in radicular and residual radicular cysts. J Appl Oral Sci (2010) 0.81
In situ normoxia enhances survival and proliferation rate of human adipose tissue-derived stromal cells without increasing the risk of tumourigenesis. PLoS One (2015) 0.81
Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in endothelial progenitor cells. Mol Cell Proteomics (2013) 0.80
RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch. Oncogene (2014) 0.80
Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence. Onco Targets Ther (2014) 0.80
VEGF activates NR2B phosphorylation through Dab1 pathway. Neurosci Lett (2013) 0.80
Rescue of hypertension-related impairment of angiogenesis by therapeutic ultrasound. Am J Transl Res (2016) 0.80
Leptin effects on the regenerative capacity of human periodontal cells. Int J Endocrinol (2014) 0.79
Soluble and insoluble signals sculpt osteogenesis in angiogenesis. World J Biol Chem (2010) 0.79
The expression of vascular endothelial growth factor in pterygium tissue of atopic patients. Int Ophthalmol (2014) 0.79
Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix. BMC Cancer (2014) 0.79
Identification of an exonic splicing silencer in exon 6A of the human VEGF gene. BMC Mol Biol (2009) 0.79
TGF-beta1 induces mouse dendritic cells to express VEGF and its receptor (Flt-1) under hypoxic conditions. Exp Mol Med (2010) 0.79
TGF beta-1 regulation of VEGF production by breast cancer cells. Ann Surg Oncol (1997) 1.63
Post-cholecystectomy symptoms after laparoscopic cholecystectomy. Ann R Coll Surg Engl (1993) 1.61
The carotid stump syndrome. Eur J Vasc Surg (1992) 1.55
Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer (2001) 1.54
Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer. Ir J Med Sci (2009) 1.50
Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer. Br J Surg (2003) 1.46
Management of patients undergoing splenectomy in an Irish teaching hospital: impact of guidelines. Ir J Med Sci (2005) 1.46
Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer. Br J Surg (2001) 1.44
A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells. Br J Cancer (2005) 1.39
The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease. Br J Cancer (1999) 1.37
Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors. Gene Ther (2009) 1.17
Host defense--a role for the amino acid taurine? JPEN J Parenter Enteral Nutr (1998) 1.16
Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation. Br J Cancer (2012) 1.14
Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer. Br J Cancer (2002) 1.07
Are elective surgical operations cancelled due to increasing medical admissions? Ir J Med Sci (2005) 1.07
Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer. Br J Cancer (2009) 1.05
The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery (1998) 1.02
Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers. Circulation (2003) 1.00
Antimetastatic activity of a cyclooxygenase-2 inhibitor. Br J Cancer (2004) 0.92
Is compliance mismatch the major cause of anastomotic arterial aneurysms? Analysis of 42 cases. J Cardiovasc Surg (Torino) (1985) 0.91
Tumour micrometastases: the influence of angiogenesis. Eur J Surg Oncol (2000) 0.91
Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo. Eur J Surg Oncol (2001) 0.90
Hemodynamic studies of the audiofrequency analysis of carotid bruits. Arch Surg (1978) 0.88
Surgical anatomy of the human spleen. Br J Surg (1989) 0.88
Digital ischaemia and palpable pedal pulses. Br J Surg (1987) 0.88
Anatomy of the peritoneal aspect of the deep inguinal ring: implications for laparoscopic inguinal herniorrhaphy. Clin Anat (1997) 0.86
Detection and identification of bursaphelenchus species with DNA fingerprinting and polymerase chain reaction. J Nematol (1993) 0.86
Blunt trauma-induced upper extremity vascular injuries. J R Coll Surg Edinb (1991) 0.86
Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. J Surg Res (2001) 0.85
Effect of intravenous taurine on endotoxin-induced acute lung injury in sheep. Eur J Surg (2001) 0.84
Thermotolerance induces heat shock protein 72 expression and protects against ischaemia-reperfusion-induced lung injury. Br J Surg (1998) 0.84
Taurine and human nutrition. Clin Nutr (1997) 0.84
Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival. Br J Cancer (2006) 0.83
Fibre optic spectrophotometry for the in vitro evaluation of ultraviolet radiation (UVR) spectral transmittance of rabbit corneas. Physiol Meas (2008) 0.83
Intestinal taurine transport: a review. Eur J Clin Invest (1997) 0.83
Thrombomodulin: tumour biology and prognostic implications. Eur J Surg Oncol (2005) 0.83
Clinically relevant thermal preconditioning attenuates ischemia-reperfusion injury. J Surg Res (2003) 0.82
Thermotolerance attenuates ischemia-reperfusion induced renal injury and increased expression of ICAM-1. Transplantation (1996) 0.81
Tight glycaemic control is a key factor in wound healing enhancement strategies in an experimental diabetes mellitus model. Ir J Med Sci (2010) 0.81
Young male smokers have altered platelets and endothelium that precedes atherosclerosis. J Surg Res (2004) 0.81
Co-immunotherapy with interleukin-2 and taurolidine for progressive metastatic melanoma. Ir J Med Sci (2006) 0.80
Hydroxy-methylglutaryl-coenzyme A reductase inhibition improves endothelial dysfunction in type-1 diabetes. Eur J Vasc Endovasc Surg (2004) 0.80
Immunonutrition and surgical practice. Proc Nutr Soc (1999) 0.80
Pharmacological induction of HSP27 attenuates intimal hyperplasia in vivo. Eur J Vasc Endovasc Surg (2003) 0.80
Pravastatin attenuates lower torso ischaemia-reperfusion-induced lung injury by upregulating constitutive endothelial nitric oxide synthase. Eur J Vasc Endovasc Surg (2001) 0.80
Herbimycin-A attenuates ischaemia-reperfusion induced pulmonary neutrophil infiltration. Eur J Vasc Endovasc Surg (1998) 0.79
Ascites revisited: a novel role for tamoxifen. Eur J Surg Oncol (1997) 0.79
Risk-based evaluation of thromboprophylaxis among surgical inpatients: are low risk patients treated unnecessarily? Ir J Med Sci (2007) 0.79
Comparison of arterial stiffness and microcirculatory changes following abdominal aortic aneurysm grafting. Ir J Med Sci (2010) 0.79
Improvement in efficacy of chemoradiotherapy by addition of an antiangiogenic agent in a murine tumor model. J Surg Res (2004) 0.79
Taurine and inflammation--a new approach to an old problem? J Leukoc Biol (1997) 0.79
Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD). Clin Exp Immunol (2005) 0.79
Significance of angiogenesis in cancer therapy. Br J Surg (1998) 0.79
Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma. Br J Cancer (2005) 0.79
Potentiation of the therapeutic index of interleukin-2 immunotherapy by combination with taurine in a syngeneic murine tumour model. Ir J Med Sci (2002) 0.79
Characterization of the defects in murine peritoneal macrophage function in the early postsplenectomy period. J Immunol (1995) 0.78
Preoperative selection of symptomatic breast cancer patients appropriate for lymphatic mapping and sentinel node biopsy. Ir J Med Sci (2007) 0.78
Oral folic acid improves endothelial dysfunction in cigarette smokers. J Surg Res (2002) 0.78
Upper limb emboli. A review of 55 patients managed surgically. J Cardiovasc Surg (Torino) (1989) 0.77
The research abstract: worth getting it right. Ir J Med Sci (2001) 0.77
Plasma factors augment neutrophil and endothelial cell activation during aortic surgery. Eur J Vasc Endovasc Surg (1997) 0.77
Interleukin-6 upregulates GP96 expression in breast cancer. J Surg Res (1997) 0.77
Taurine attenuates recombinant interleukin-2-activated, lymphocyte-mediated endothelial cell injury. Cancer (1998) 0.77
Traumatic pseudoaneurysm of the internal carotid artery presenting with oculosympathetic palsy. Ir J Med Sci (2005) 0.77
Inosine modulates gut barrier dysfunction and end organ damage in a model of ischemia-reperfusion injury. J Surg Res (2002) 0.76
Diethylmaleate, a pro-oxidant, attenuates experimental ischaemia-reperfusion-induced lung injury. Br J Surg (2002) 0.76
Taurine attenuates LPS-induced rolling and adhesion in rat microcirculation. J Surg Res (2001) 0.76
Practice patterns in flexor tendon repair. Ir J Med Sci (2007) 0.76
Nitric oxide attenuates interleukin 2-induced lung injury. Br J Surg (1997) 0.76
Oral-activated charcoal in the diagnosis of enterovesical fistulae. Ir J Med Sci (2003) 0.75
The role of CT in the management of carcinoma of the oesophagus and cardia. Ann R Coll Surg Engl (1987) 0.75
Polyvinyl chloride T-tubes. Br Med J (1973) 0.75
Taurine attenuates radiation-induced lung fibrosis in C57/Bl6 fibrosis prone mice. Ir J Med Sci (2009) 0.75
Increased tumor establishment and growth after laparotomy vs laparoscopy. Arch Surg (1996) 0.75
Systemic Weber-Christian disease with portal hypertension and oesophageal varices. J R Soc Med (1988) 0.75
The use of ultrasound in the confirmation and evaluation of abdominal aortic aneurysms. Ir Med J (1985) 0.75
Genetic evaluation of lipoprotein(a) in intracranial aneurysm disease. Neurosurgery (2001) 0.75
The evolution of trauma services at Beaumont Hospital. Ir J Med Sci (2007) 0.75
An "all comers" policy for ruptured abdominal aortic aneurysms: how can results be improved? Eur J Surg (1998) 0.75
Recombinant bactericidal permeability increasing protein (rBPI21) inhibits surgery-induced tumour growth in a murine model of metastatic disease. Ir J Med Sci (2008) 0.75
Glutamine preconditioning protects against local and systemic injury induced by orthopaedic surgery. J Nutr Health Aging (2012) 0.75
Conservative management of epiploic appendagitis based on CT scan findings. Ir J Med Sci (2005) 0.75
Myeloperoxidase (MPO) may mediate neutrophil adherence to the endothelium through upregulation of CD11B expression--an effect downregulated by taurine. Adv Exp Med Biol (1998) 0.75
Transient reduction in gastric acid secretion following gastric mucosal laser irradiation. Surg Laparosc Endosc (1998) 0.75
Hydroxymethylglutaryl co-enzyme A reductase inhibition attenuates endotoxin-mediated inflammatory responses. Br J Surg (2005) 0.75
The evolving rationale of elective treatment of abdominal aortic aneurysms. Surgeon (2005) 0.75
Preconditioning and its clinical potential. Ir J Med Sci (2009) 0.75
Videos: acute hyperglycaemia induced microvascular injury and haemorrhage in an experimental model. Ir J Med Sci (2008) 0.75
The Greenfield filter: an advance in pulmonary embolism management. Ir J Med Sci (1984) 0.75